The clinical performance of an office-based risk scoring system for fatal cardiovascular diseases in North-East of Iran

Cardiovascular diseases (CVD) are becoming major causes of death in developing countries. Risk scoring systems for CVD are needed to prioritize allocation of limited resources. Most of these risk score algorithms have been based on a long array of risk factors including blood markers of lipids. Howe...

Full description

Saved in:
Bibliographic Details
Published in:PloS one Vol. 10; no. 5; p. e0126779
Main Authors: Sepanlou, Sadaf G, Malekzadeh, Reza, Poustchi, Hossein, Sharafkhah, Maryam, Ghodsi, Saeed, Malekzadeh, Fatemeh, Etemadi, Arash, Pourshams, Akram, Pharoah, Paul D, Abnet, Christian C, Brennan, Paul, Boffetta, Paolo, Dawsey, Sanford M, Kamangar, Farin
Format: Journal Article
Language:English
Published: United States Public Library of Science 26-05-2015
Public Library of Science (PLoS)
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiovascular diseases (CVD) are becoming major causes of death in developing countries. Risk scoring systems for CVD are needed to prioritize allocation of limited resources. Most of these risk score algorithms have been based on a long array of risk factors including blood markers of lipids. However, risk scoring systems that solely use office-based data, not including laboratory markers, may be advantageous. In the current analysis, we validated the office-based Framingham risk scoring system in Iran. The study used data from the Golestan Cohort in North-East of Iran. The following risk factors were used in the development of the risk scoring method: sex, age, body mass index, systolic blood pressure, hypertension treatment, current smoking, and diabetes. Cardiovascular risk functions for prediction of 10-year risk of fatal CVDs were developed. A total of 46,674 participants free of CVD at baseline were included. Predictive value of estimated risks was examined. The resulting Area Under the ROC Curve (AUC) was 0.774 (95% CI: 0.762-0.787) in all participants, 0.772 (95% CI: 0.753-0.791) in women, and 0.763 (95% CI: 0.747-0.779) in men. AUC was higher in urban areas (0.790, 95% CI: 0.766-0.815). The predicted and observed risks of fatal CVD were similar in women. However, in men, predicted probabilities were higher than observed. The AUC in the current study is comparable to results of previous studies while lipid profile was replaced by body mass index to develop an office-based scoring system. This scoring algorithm is capable of discriminating individuals at high risk versus low risk of fatal CVD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Conceived and designed the experiments: SGS RM FK HP AE AP FM PDP CCA P. Brennan P. Boffetta SMD. Performed the experiments: RM HP AE AP FK FM PDP CCA P. Brennan SMD SGS. Analyzed the data: SGS FK MS SMD SG. Contributed reagents/materials/analysis tools: SGS RM FK HP AE AP FM PDP CCA P. Boffetta SMD. Wrote the paper: SGS FK P. Boffetta SMD MS SG RM MS. Managed the entire process of the Golestan Cohort Study: AP HP RM.
Competing Interests: The authors have declared that no competing interests exist.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0126779